Cargando…
ARNi: A Novel Approach to Counteract Cardiovascular Diseases
Cardiovascular diseases (CVDs) still represent the greatest burden on healthcare systems worldwide. Despite the enormous efforts over the last twenty years to limit the spread of cardiovascular risk factors, their prevalence is growing and control is still suboptimal. Therefore, the availability of...
Autores principales: | Volpe, Massimo, Rubattu, Speranza, Battistoni, Allegra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539682/ https://www.ncbi.nlm.nih.gov/pubmed/31035359 http://dx.doi.org/10.3390/ijms20092092 |
Ejemplares similares
-
Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
por: Rubattu, Speranza, et al.
Publicado: (2020) -
Hypertension in the elderly: which are the blood pressure threshold values?
por: Volpe, Massimo, et al.
Publicado: (2019) -
Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases
por: RUBATTU, SPERANZA, et al.
Publicado: (2006) -
Editorial: Natriuretic Peptides in Cardiovascular Pathophysiology
por: Volpe, Massimo, et al.
Publicado: (2022) -
From ARB to ARNI in Cardiovascular Control
por: Uijl, Estrellita, et al.
Publicado: (2016)